JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 12, 2003; DOI: 10.1124/jpet.102.047217


0022-3565/03/3063-846-854$20.00
JPET 306:846-854, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.102.047217v1
306/3/846    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enomoto, N.
Right arrow Articles by Sato, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enomoto, N.
Right arrow Articles by Sato, N.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Prevention of Ethanol-Induced Liver Injury in Rats by an Agonist of Peroxisome Proliferator-Activated Receptor-{gamma}, Pioglitazone

Nobuyuki Enomoto, Yoshiyuki Takei, Miyoko Hirose, Akira Konno, Tomoyoshi Shibuya, Shujiro Matsuyama, Satoko Suzuki, Kenichi Ikejima Tsuneo Kitamura, and Nobuhiro Sato

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan

Agonists of peroxisome proliferator-activated receptor (PPAR)-{gamma} have been shown to reduce tumor necrosis factor-{alpha} (TNF-{alpha})-induced insulin resistance. On the other hand, sensitization of Kupffer cells to lipopolysaccharide (LPS) and their production of TNF-{alpha} are critical for progression of alcoholic liver injury. This study was intended to determine whether pioglitazone, a PPAR-{gamma} agonist, could prevent alcohol-induced liver injury. Rats were given ethanol (5 g/kg b.wt.) and pioglitazone (500 µg/kg) once every 24 h intragastrically. Ethanol for 8 weeks caused pronounced steatosis, necrosis, and inflammation in the liver. These pathological parameters were diminished greatly by pioglitazone. Kupffer cells were sensitized to LPS after ethanol for 4 weeks as evidenced by aggravation of liver pathology induced by LPS (5 mg/kg) and enhancement of LPS (100 ng/ml)-induced intracellular Ca2+ concentration elevation in Kupffer cells. The parameters were diminished by treatment with pioglitazone. LPS-induced TNF-{alpha} production by Kupffer cells from the 4-week ethanol group was 3 to 4 times higher than control. This increase was blunted by 70% with pioglitazone. Gut permeability was 10-fold higher in the 4-week ethanol group, and pioglitazone treatment did not change the value. Inclusion of TNF-{alpha} in culture media of Kupffer cells enhanced CD14 expression, LPS-induced intracellular Ca2+ concentration response, and production of TNF-{alpha}. These results indicate that pioglitazone prevents alcoholic liver injury through abrogation of Kupffer cell sensitization to LPS.


Received March 17, 2003; accepted May 27, 2003.

Address correspondence to: Dr. Nobuhiro Sato, Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. E-mail: nsato{at}med.juntendo.ac.jp




This article has been cited by other articles:


Home page
Toxicol SciHome page
W. Shan, P. S. Palkar, I. A. Murray, E. I. McDevitt, M. J. Kennett, B. H. Kang, H. C. Isom, G. H. Perdew, F. J. Gonzalez, and J. M. Peters
Ligand Activation of Peroxisome Proliferator-Activated Receptor {beta}/{delta} (PPAR{beta}/{delta}) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression
Toxicol. Sci., October 1, 2008; 105(2): 418 - 428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. M. Ajmo, X. Liang, C. Q. Rogers, B. Pennock, and M. You
Resveratrol alleviates alcoholic fatty liver in mice
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G833 - G842.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Miksa, R. Wu, X. Cui, W. Dong, P. Das, H. H. Simms, T. S. Ravikumar, and P. Wang
Vasoactive Hormone Adrenomedullin and Its Binding Protein: Anti-Inflammatory Effects by Up-Regulating Peroxisome Proliferator-Activated Receptor-{gamma}
J. Immunol., November 1, 2007; 179(9): 6263 - 6272.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
I A Leclercq, C Sempoux, P Starkel, and Y Horsmans
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats
Gut, July 1, 2006; 55(7): 1020 - 1029.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Knight, B. B. Yeap, G. C. Yeoh, and J. K. Olynyk
Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member {gamma}, but not {alpha} or {delta}
Carcinogenesis, October 1, 2005; 26(10): 1782 - 1792.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A M Diehl, Z P Li, H Z Lin, and S Q Yang
Cytokines and the pathogenesis of non-alcoholic steatohepatitis
Gut, February 1, 2005; 54(2): 303 - 306.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.